Company Filing History:
1 out of 126 
1 out of 166 
1 out of 330 
Years Active: 1997-2003
Title: Albert Hinnen - A Pioneer in Antimycotic Research
Introduction
Albert Hinnen is a distinguished inventor based in Jena, Germany, recognized for his contributions to the field of antimycotic research. With a total of three patents to his name, Hinnen's work focuses on identifying and developing inhibitors for specific chemical processes, which has significant implications in medical applications.
Latest Patents
Hinnen's latest patents highlight his innovative approach to addressing resistance in antifungal treatments. One such patent is a method for screening antimycotically active substances. Additionally, he developed a method for identifying inhibitors of soraphen A resistant pathways. His patented assay identifies these inhibitors by measuring the reactivity of acetyl-coenzyme A carboxylase in the presence and absence of suspected compounds, facilitating the distinction of effective inhibitors against soraphen A resistant strains.
Career Highlights
Throughout his career, Albert Hinnen has been associated with prominent organizations, including Novartis Finance Corporation and Novartis Corporation. His contributions in these roles have not only advanced the company's research efforts but have also pushed the boundaries of pharmaceutical innovations.
Collaborations
Hinnen has collaborated with various professionals, including notable coworkers such as Hans-Friedrich Vahlensieck and Johannes Hegemann. These partnerships have enriched his research environment, fostering the exchange of ideas essential for driving innovation in antifungal solutions.
Conclusion
With his groundbreaking patents and extensive career, Albert Hinnen stands out as a key figure in the field of antimycotic research. His work continues to influence future developments in pharmaceuticals, especially concerning the resistance faced by current antifungal treatments.